Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Influenza, Human | 41 | 2018 | 124 | 8.670 |
Why?
|
Influenza Vaccines | 26 | 2018 | 79 | 4.980 |
Why?
|
Vaccination | 15 | 2019 | 137 | 2.590 |
Why?
|
Hospitalization | 20 | 2014 | 465 | 2.330 |
Why?
|
Infant | 50 | 2020 | 1076 | 2.190 |
Why?
|
Child, Preschool | 52 | 2020 | 1281 | 2.150 |
Why?
|
Influenza A Virus, H1N1 Subtype | 7 | 2018 | 49 | 2.090 |
Why?
|
Pneumococcal Infections | 12 | 2010 | 30 | 2.060 |
Why?
|
Pneumococcal Vaccines | 10 | 2009 | 26 | 1.850 |
Why?
|
Population Surveillance | 15 | 2015 | 124 | 1.460 |
Why?
|
Child | 33 | 2020 | 2472 | 1.310 |
Why?
|
Immunization Programs | 8 | 2014 | 26 | 1.280 |
Why?
|
Immunization Schedule | 7 | 2020 | 26 | 1.150 |
Why?
|
Influenza B virus | 8 | 2018 | 20 | 1.090 |
Why?
|
Emergency Service, Hospital | 10 | 2016 | 463 | 1.050 |
Why?
|
Streptococcus pneumoniae | 9 | 2015 | 39 | 1.040 |
Why?
|
Humans | 78 | 2020 | 32297 | 0.950 |
Why?
|
Pediatrics | 4 | 2017 | 158 | 0.940 |
Why?
|
Adolescent | 25 | 2020 | 3571 | 0.910 |
Why?
|
Respiratory Tract Infections | 7 | 2018 | 42 | 0.910 |
Why?
|
Meningococcal Vaccines | 3 | 2007 | 9 | 0.860 |
Why?
|
Influenza A virus | 7 | 2012 | 21 | 0.810 |
Why?
|
Female | 51 | 2019 | 20126 | 0.790 |
Why?
|
Male | 51 | 2019 | 19488 | 0.780 |
Why?
|
Orthomyxoviridae | 4 | 2014 | 14 | 0.760 |
Why?
|
Whooping Cough | 2 | 2012 | 11 | 0.750 |
Why?
|
Diphtheria-Tetanus-acellular Pertussis Vaccines | 2 | 2012 | 8 | 0.750 |
Why?
|
Age Distribution | 8 | 2014 | 210 | 0.750 |
Why?
|
Infant, Newborn | 17 | 2016 | 681 | 0.740 |
Why?
|
Pneumonia, Pneumococcal | 2 | 2013 | 12 | 0.690 |
Why?
|
Antibodies, Viral | 2 | 2014 | 60 | 0.690 |
Why?
|
Prospective Studies | 16 | 2018 | 2274 | 0.660 |
Why?
|
United States | 23 | 2020 | 3983 | 0.640 |
Why?
|
Immunization | 2 | 2020 | 35 | 0.620 |
Why?
|
Respiratory Syncytial Virus Infections | 5 | 2013 | 10 | 0.600 |
Why?
|
Influenza A Virus, H3N2 Subtype | 5 | 2018 | 23 | 0.590 |
Why?
|
Parents | 4 | 2017 | 150 | 0.590 |
Why?
|
Registries | 3 | 2019 | 300 | 0.580 |
Why?
|
Patient-Centered Care | 1 | 2017 | 74 | 0.580 |
Why?
|
Continuity of Patient Care | 1 | 2017 | 70 | 0.580 |
Why?
|
Family Characteristics | 2 | 2014 | 33 | 0.570 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 126 | 0.560 |
Why?
|
Quality of Health Care | 1 | 2017 | 151 | 0.560 |
Why?
|
Guideline Adherence | 2 | 2009 | 122 | 0.560 |
Why?
|
Patient Acceptance of Health Care | 2 | 2012 | 171 | 0.560 |
Why?
|
Tennessee | 11 | 2013 | 101 | 0.550 |
Why?
|
Chronic Disease | 1 | 2017 | 406 | 0.540 |
Why?
|
Body Weight | 1 | 2018 | 311 | 0.540 |
Why?
|
Reagent Kits, Diagnostic | 3 | 2012 | 13 | 0.540 |
Why?
|
Overweight | 1 | 2018 | 270 | 0.540 |
Why?
|
Middle Ear Ventilation | 3 | 2015 | 9 | 0.530 |
Why?
|
Otitis Media with Effusion | 3 | 2015 | 10 | 0.530 |
Why?
|
Curriculum | 1 | 2017 | 210 | 0.530 |
Why?
|
North Carolina | 7 | 2016 | 1520 | 0.510 |
Why?
|
Clinical Medicine | 1 | 2015 | 13 | 0.510 |
Why?
|
Medical Records | 2 | 2013 | 77 | 0.510 |
Why?
|
Point-of-Care Systems | 2 | 2006 | 45 | 0.480 |
Why?
|
Antiviral Agents | 2 | 2013 | 110 | 0.480 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2012 | 353 | 0.470 |
Why?
|
Decision Support Techniques | 1 | 2015 | 128 | 0.470 |
Why?
|
Young Adult | 7 | 2019 | 2626 | 0.440 |
Why?
|
Primary Health Care | 2 | 2013 | 221 | 0.430 |
Why?
|
Critical Care | 1 | 2014 | 117 | 0.430 |
Why?
|
Rotavirus Vaccines | 1 | 2012 | 6 | 0.410 |
Why?
|
Seasons | 7 | 2018 | 86 | 0.410 |
Why?
|
Rotavirus Infections | 1 | 2012 | 9 | 0.410 |
Why?
|
Scientific Misconduct | 1 | 2012 | 4 | 0.410 |
Why?
|
Conflict of Interest | 1 | 2012 | 39 | 0.400 |
Why?
|
Periodicals as Topic | 2 | 2019 | 101 | 0.400 |
Why?
|
Health Policy | 1 | 2012 | 85 | 0.390 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2011 | 2 | 0.390 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2011 | 32 | 0.380 |
Why?
|
Otitis Media | 3 | 2006 | 23 | 0.370 |
Why?
|
Hemoglobin C | 1 | 2010 | 2 | 0.370 |
Why?
|
Ambulatory Care | 4 | 2009 | 108 | 0.360 |
Why?
|
Sickle Cell Trait | 1 | 2010 | 14 | 0.360 |
Why?
|
Adult | 14 | 2019 | 9467 | 0.350 |
Why?
|
Health Services Research | 1 | 2009 | 82 | 0.320 |
Why?
|
Vaccines, Inactivated | 6 | 2018 | 38 | 0.310 |
Why?
|
Mental Recall | 1 | 2007 | 51 | 0.300 |
Why?
|
Medication Adherence | 1 | 2009 | 161 | 0.300 |
Why?
|
Health Services Accessibility | 1 | 2009 | 242 | 0.290 |
Why?
|
Ambulatory Care Facilities | 1 | 2007 | 83 | 0.290 |
Why?
|
New York | 5 | 2013 | 22 | 0.290 |
Why?
|
Incidence | 9 | 2014 | 1207 | 0.280 |
Why?
|
Mass Media | 1 | 2006 | 12 | 0.270 |
Why?
|
Vaccines, Attenuated | 4 | 2018 | 12 | 0.270 |
Why?
|
Sensitivity and Specificity | 7 | 2011 | 600 | 0.270 |
Why?
|
Editorial Policies | 2 | 2019 | 15 | 0.270 |
Why?
|
Middle Aged | 15 | 2016 | 11949 | 0.250 |
Why?
|
Cross-Sectional Studies | 5 | 2013 | 1522 | 0.250 |
Why?
|
Case-Control Studies | 7 | 2018 | 911 | 0.250 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2013 | 264 | 0.240 |
Why?
|
Haemophilus influenzae | 2 | 2015 | 13 | 0.240 |
Why?
|
Practice Guidelines as Topic | 4 | 2011 | 410 | 0.240 |
Why?
|
Vaccines, Conjugate | 5 | 2006 | 17 | 0.230 |
Why?
|
Logistic Models | 5 | 2018 | 788 | 0.230 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2003 | 24 | 0.230 |
Why?
|
Clinical Trials as Topic | 2 | 2019 | 316 | 0.230 |
Why?
|
Medicaid | 1 | 2003 | 95 | 0.220 |
Why?
|
Child, Hospitalized | 1 | 2002 | 8 | 0.210 |
Why?
|
Immunoassay | 1 | 2002 | 14 | 0.210 |
Why?
|
Cohort Studies | 7 | 2011 | 1832 | 0.210 |
Why?
|
Seizures, Febrile | 1 | 2001 | 1 | 0.200 |
Why?
|
Orthomyxoviridae Infections | 1 | 2001 | 20 | 0.200 |
Why?
|
Health Care Surveys | 3 | 2012 | 187 | 0.200 |
Why?
|
Polymerase Chain Reaction | 4 | 2013 | 190 | 0.190 |
Why?
|
Models, Theoretical | 2 | 2015 | 138 | 0.190 |
Why?
|
Vaccines | 1 | 2020 | 6 | 0.180 |
Why?
|
Time Factors | 3 | 2014 | 2181 | 0.180 |
Why?
|
Nose | 2 | 2018 | 13 | 0.170 |
Why?
|
Acute Disease | 2 | 2018 | 255 | 0.170 |
Why?
|
Hospital Costs | 2 | 2010 | 38 | 0.170 |
Why?
|
Papillomavirus Vaccines | 1 | 2019 | 44 | 0.160 |
Why?
|
Sex Distribution | 4 | 2008 | 201 | 0.160 |
Why?
|
Serotyping | 3 | 2007 | 15 | 0.160 |
Why?
|
Respiratory Syncytial Viruses | 4 | 2009 | 6 | 0.160 |
Why?
|
Papillomavirus Infections | 1 | 2019 | 65 | 0.160 |
Why?
|
Education, Medical | 1 | 2019 | 70 | 0.160 |
Why?
|
Pregnancy | 2 | 2012 | 1010 | 0.160 |
Why?
|
Focus Groups | 1 | 2017 | 111 | 0.150 |
Why?
|
Needs Assessment | 1 | 2017 | 78 | 0.150 |
Why?
|
Retrospective Studies | 7 | 2015 | 3514 | 0.150 |
Why?
|
Asthma | 4 | 2013 | 438 | 0.140 |
Why?
|
Risk Factors | 6 | 2010 | 3876 | 0.140 |
Why?
|
School Health Services | 2 | 2014 | 18 | 0.140 |
Why?
|
Predictive Value of Tests | 4 | 2010 | 877 | 0.140 |
Why?
|
Pilot Projects | 1 | 2017 | 536 | 0.130 |
Why?
|
Reproducibility of Results | 3 | 2007 | 779 | 0.130 |
Why?
|
Carnobacteriaceae | 1 | 2015 | 3 | 0.130 |
Why?
|
Bacterial Infections | 1 | 2015 | 52 | 0.120 |
Why?
|
European Continental Ancestry Group | 2 | 2013 | 1180 | 0.120 |
Why?
|
Parental Consent | 1 | 2014 | 5 | 0.120 |
Why?
|
Medical Oncology | 2 | 2006 | 84 | 0.110 |
Why?
|
Schools | 1 | 2014 | 65 | 0.110 |
Why?
|
Cooperative Behavior | 1 | 2014 | 80 | 0.110 |
Why?
|
Shock | 1 | 2013 | 29 | 0.110 |
Why?
|
Risk Assessment | 4 | 2008 | 1447 | 0.110 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2013 | 16 | 0.110 |
Why?
|
Utilization Review | 1 | 2013 | 17 | 0.110 |
Why?
|
Limit of Detection | 1 | 2012 | 15 | 0.110 |
Why?
|
Ohio | 1 | 2013 | 58 | 0.110 |
Why?
|
Age Factors | 3 | 2013 | 1204 | 0.110 |
Why?
|
Craniocerebral Trauma | 1 | 2013 | 57 | 0.110 |
Why?
|
Pharynx | 2 | 2017 | 13 | 0.110 |
Why?
|
Gram-Positive Cocci | 1 | 2012 | 4 | 0.110 |
Why?
|
Health Status | 2 | 2007 | 402 | 0.100 |
Why?
|
Postpartum Period | 1 | 2012 | 34 | 0.100 |
Why?
|
Gastroenteritis | 1 | 2012 | 12 | 0.100 |
Why?
|
Healthy People Programs | 1 | 2012 | 3 | 0.100 |
Why?
|
Tonsillitis | 1 | 2012 | 5 | 0.100 |
Why?
|
Palatine Tonsil | 1 | 2012 | 6 | 0.100 |
Why?
|
Streptococcus pyogenes | 1 | 2012 | 16 | 0.100 |
Why?
|
Electronic Mail | 1 | 2012 | 18 | 0.100 |
Why?
|
Streptococcal Infections | 1 | 2012 | 22 | 0.100 |
Why?
|
Disclosure | 1 | 2012 | 39 | 0.100 |
Why?
|
Program Evaluation | 1 | 2012 | 186 | 0.100 |
Why?
|
Health Expenditures | 1 | 2012 | 66 | 0.100 |
Why?
|
Social Behavior | 1 | 2012 | 65 | 0.100 |
Why?
|
Antigens, Viral | 2 | 2010 | 21 | 0.100 |
Why?
|
Universities | 1 | 2012 | 150 | 0.090 |
Why?
|
Analysis of Variance | 1 | 2012 | 470 | 0.090 |
Why?
|
Diagnostic Tests, Routine | 1 | 2010 | 24 | 0.090 |
Why?
|
Comorbidity | 4 | 2008 | 572 | 0.090 |
Why?
|
Aged | 6 | 2015 | 10398 | 0.090 |
Why?
|
Office Visits | 3 | 2008 | 73 | 0.090 |
Why?
|
Obesity | 1 | 2018 | 1164 | 0.090 |
Why?
|
Internet | 1 | 2012 | 203 | 0.090 |
Why?
|
Students | 1 | 2012 | 175 | 0.090 |
Why?
|
Aged, 80 and over | 2 | 2015 | 4050 | 0.090 |
Why?
|
Risk | 1 | 2011 | 325 | 0.090 |
Why?
|
Follow-Up Studies | 4 | 2008 | 2296 | 0.090 |
Why?
|
Guidelines as Topic | 1 | 2009 | 48 | 0.090 |
Why?
|
Respirovirus Infections | 1 | 2009 | 2 | 0.080 |
Why?
|
Croup | 1 | 2009 | 3 | 0.080 |
Why?
|
Poisson Distribution | 1 | 2008 | 17 | 0.080 |
Why?
|
Severity of Illness Index | 3 | 2013 | 926 | 0.080 |
Why?
|
Fluorescent Antibody Technique | 2 | 2012 | 94 | 0.080 |
Why?
|
Virus Cultivation | 2 | 2010 | 3 | 0.080 |
Why?
|
Medical History Taking | 1 | 2007 | 37 | 0.080 |
Why?
|
Alaska | 1 | 2007 | 2 | 0.070 |
Why?
|
Inuits | 1 | 2007 | 2 | 0.070 |
Why?
|
Abdominal Pain | 2 | 2005 | 45 | 0.070 |
Why?
|
Picornaviridae Infections | 1 | 2007 | 4 | 0.070 |
Why?
|
Rhinovirus | 1 | 2007 | 9 | 0.070 |
Why?
|
Indians, North American | 1 | 2007 | 109 | 0.070 |
Why?
|
Secondary Prevention | 1 | 2007 | 65 | 0.070 |
Why?
|
Nasal Cavity | 1 | 2006 | 5 | 0.070 |
Why?
|
Immunity, Herd | 1 | 2006 | 6 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2006 | 696 | 0.070 |
Why?
|
Hospice Care | 1 | 2006 | 13 | 0.070 |
Why?
|
Drug Resistance, Bacterial | 1 | 2006 | 42 | 0.070 |
Why?
|
Neoplasms | 2 | 2019 | 695 | 0.070 |
Why?
|
African Americans | 1 | 2013 | 1443 | 0.060 |
Why?
|
Oxycodone | 1 | 2005 | 7 | 0.060 |
Why?
|
Diagnostic Errors | 1 | 2005 | 46 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 759 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2006 | 140 | 0.060 |
Why?
|
Paramyxoviridae Infections | 1 | 2004 | 2 | 0.060 |
Why?
|
Animals | 2 | 2014 | 7694 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2017 | 3358 | 0.060 |
Why?
|
Emergency Medical Services | 1 | 2006 | 165 | 0.060 |
Why?
|
Child Health Services | 1 | 2003 | 24 | 0.060 |
Why?
|
African Continental Ancestry Group | 1 | 2004 | 364 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2005 | 262 | 0.050 |
Why?
|
Linear Models | 1 | 2003 | 454 | 0.050 |
Why?
|
Health Care Costs | 1 | 2003 | 118 | 0.050 |
Why?
|
Communication Barriers | 1 | 2001 | 22 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2003 | 250 | 0.050 |
Why?
|
Brain Diseases | 1 | 2001 | 39 | 0.050 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2001 | 4 | 0.050 |
Why?
|
Neuraminidase | 1 | 2001 | 10 | 0.050 |
Why?
|
Blood Coagulation Disorders | 1 | 2001 | 12 | 0.050 |
Why?
|
Warfarin | 1 | 2001 | 32 | 0.050 |
Why?
|
Medical Errors | 1 | 2001 | 38 | 0.050 |
Why?
|
Advisory Committees | 1 | 2020 | 37 | 0.040 |
Why?
|
Anticoagulants | 1 | 2001 | 127 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2001 | 276 | 0.040 |
Why?
|
Patient Participation | 1 | 2019 | 81 | 0.040 |
Why?
|
Fever | 2 | 2009 | 63 | 0.040 |
Why?
|
Cell Line | 2 | 2010 | 462 | 0.040 |
Why?
|
Suppuration | 1 | 2015 | 6 | 0.030 |
Why?
|
Ear, Middle | 1 | 2015 | 9 | 0.030 |
Why?
|
Disease Outbreaks | 1 | 2015 | 38 | 0.030 |
Why?
|
Emergencies | 1 | 2014 | 47 | 0.030 |
Why?
|
Computer Simulation | 1 | 2015 | 220 | 0.030 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2013 | 48 | 0.030 |
Why?
|
Infant, Premature, Diseases | 1 | 2013 | 25 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2013 | 120 | 0.030 |
Why?
|
Hemorrhage | 1 | 2013 | 101 | 0.030 |
Why?
|
Tonsillectomy | 1 | 2012 | 10 | 0.030 |
Why?
|
Hypertrophy | 1 | 2012 | 27 | 0.030 |
Why?
|
Biofilms | 1 | 2012 | 26 | 0.030 |
Why?
|
Medical Audit | 1 | 2011 | 16 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 88 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2012 | 99 | 0.030 |
Why?
|
Health Status Disparities | 1 | 2013 | 124 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 2013 | 422 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2012 | 263 | 0.020 |
Why?
|
Recurrence | 1 | 2012 | 266 | 0.020 |
Why?
|
Sex Factors | 1 | 2013 | 674 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2013 | 267 | 0.020 |
Why?
|
Paramyxovirinae | 1 | 2009 | 2 | 0.020 |
Why?
|
Bronchiolitis | 1 | 2009 | 3 | 0.020 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2009 | 9 | 0.020 |
Why?
|
Apnea | 1 | 2009 | 6 | 0.020 |
Why?
|
Community-Acquired Infections | 1 | 2009 | 32 | 0.020 |
Why?
|
Total Quality Management | 1 | 2008 | 18 | 0.020 |
Why?
|
Communicable Disease Control | 1 | 2008 | 15 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2008 | 131 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 302 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2009 | 118 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 133 | 0.020 |
Why?
|
Probability | 1 | 2008 | 160 | 0.020 |
Why?
|
Reference Values | 1 | 2008 | 255 | 0.020 |
Why?
|
Sepsis | 1 | 2009 | 156 | 0.020 |
Why?
|
Health Surveys | 1 | 2008 | 202 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2007 | 32 | 0.020 |
Why?
|
Outpatients | 1 | 2006 | 58 | 0.020 |
Why?
|
Terminal Care | 1 | 2006 | 24 | 0.020 |
Why?
|
Photoperiod | 1 | 2005 | 3 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2005 | 150 | 0.020 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2004 | 14 | 0.020 |
Why?
|
Drug Resistance, Microbial | 1 | 2004 | 14 | 0.020 |
Why?
|
Administration, Oral | 1 | 2005 | 185 | 0.020 |
Why?
|
Paramyxoviridae | 1 | 2004 | 2 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2007 | 736 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2004 | 64 | 0.020 |
Why?
|
Viral Vaccines | 1 | 2004 | 13 | 0.020 |
Why?
|
Specimen Handling | 1 | 2004 | 35 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2006 | 218 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2005 | 550 | 0.010 |
Why?
|
Pain Measurement | 1 | 2005 | 370 | 0.010 |
Why?
|
Pain | 1 | 2006 | 305 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2005 | 511 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2004 | 309 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2004 | 786 | 0.010 |
Why?
|
Prothrombin Time | 1 | 2001 | 3 | 0.010 |
Why?
|
Partial Thromboplastin Time | 1 | 2001 | 7 | 0.010 |
Why?
|
Angina, Unstable | 1 | 2001 | 21 | 0.010 |
Why?
|
Fever of Unknown Origin | 1 | 2001 | 10 | 0.010 |
Why?
|
Nausea | 1 | 2001 | 54 | 0.010 |
Why?
|
Renal Dialysis | 1 | 2001 | 282 | 0.010 |
Why?
|